Brief: China Regenerative Medicine International Group updates on product expansion
05/09/2017 10:41
Sept 5 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* Group is expanding clinical applications of its
bioengineered cornea in ophthalmological surgeries
Source text: (bit.ly/2eFMhQm)
Further company coverage: 8158.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital